Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Data Brief: Healthcare Utilization for Vaso-Occlusive Episodes by People with Sickle Cell Disease in California and Georgia, 2015
source: Centers for Disease Control and Prevention
year: 2020
summary/abstract:Many people with sickle cell disease (SCD) had a hospitalization or an emergency department (ED) visit with a vaso-occlusive episode (VOE), or pain crisis, diagnosis code.
People with SCD:
• Go to the hospital more than once a year, with an average stay of 5 days per hospitalization.
• Go to the ED an average of 2–3 times a year.
• Go to the ED and hospital most commonly for VOEs.
More than 4 in 10 (41%) ED visits and more than 7 in 10 (73%) hospital admissions for people with SCD in California had a VOE diagnosis code.
Nearly 1 in 2 (48%) ED visits and 3 in 4 (75%) hospital admissions for people with SCD in Georgia had a VOE diagnosis code.
read more
+myBinderRelated Content
-
Safety and early hints of benefit seen in phase 1b trial of PF-04447943Sickle cell disease (SCD) patients were ...
-
Higher Prevalence of Hydroxyurea Use Is Associated with Lower Hospitalization Rate in a Population of Children with ...Background: Individuals with sickle cel...
-
The 14th Annual Sickle Cell Disease Research & Educational Symposium and 43rd National Sickle Cell Disease Scie...The Symposium is an exciting three-day m...
-
A survey of sickle cell patients transitioned to adult care from Texas children’s hematology center between Januar...An estimated 93-98% of sickle cell disea...
-
Prodigy’s death shines light on slow progress against sickle cell diseaseThe death of the rap artist Prodigy (Alb...
-
New Research Suggests SANGUINATE™ Reduces the Number of Sickled Red Blood Cells in Patients with Vaso-Occlusive Cr...SANGUINATE™, the only investigational ...
-
RARE Drug Development SymposiumThe RARE Drug Development Symposium is a...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.